ATE249233T1 - Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen - Google Patents

Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen

Info

Publication number
ATE249233T1
ATE249233T1 AT97104590T AT97104590T ATE249233T1 AT E249233 T1 ATE249233 T1 AT E249233T1 AT 97104590 T AT97104590 T AT 97104590T AT 97104590 T AT97104590 T AT 97104590T AT E249233 T1 ATE249233 T1 AT E249233T1
Authority
AT
Austria
Prior art keywords
releasing hormone
production
carcinoma
additional
gonadotropin releasing
Prior art date
Application number
AT97104590T
Other languages
English (en)
Inventor
Gary D Hodgen
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24472058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE249233(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Application granted granted Critical
Publication of ATE249233T1 publication Critical patent/ATE249233T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT97104590T 1996-03-18 1997-03-18 Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen ATE249233T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/617,048 US5691314A (en) 1996-03-18 1996-03-18 Adjunctive therapy

Publications (1)

Publication Number Publication Date
ATE249233T1 true ATE249233T1 (de) 2003-09-15

Family

ID=24472058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97104590T ATE249233T1 (de) 1996-03-18 1997-03-18 Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen

Country Status (7)

Country Link
US (2) US5691314A (de)
EP (1) EP0796622B1 (de)
AT (1) ATE249233T1 (de)
DE (1) DE69724682T2 (de)
DK (1) DK0796622T3 (de)
ES (1) ES2206622T3 (de)
PT (1) PT796622E (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6254601B1 (en) 1998-12-08 2001-07-03 Hysterx, Inc. Methods for occlusion of the uterine arteries
US7223279B2 (en) 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US6550482B1 (en) 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US6638286B1 (en) 2000-11-16 2003-10-28 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6635065B2 (en) 2000-11-16 2003-10-21 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US7354444B2 (en) 2001-03-28 2008-04-08 Vascular Control Systems, Inc. Occlusion device with deployable paddles for detection and occlusion of blood vessels
WO2002078549A2 (en) * 2001-03-28 2002-10-10 Vascular Control Systems, Inc. Method and apparatus for the detection and ligation of uterine arteries
US7207996B2 (en) 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US7172603B2 (en) * 2002-11-19 2007-02-06 Vascular Control Systems, Inc. Deployable constrictor for uterine artery occlusion
US20040097961A1 (en) * 2002-11-19 2004-05-20 Vascular Control System Tenaculum for use with occlusion devices
US7404821B2 (en) 2003-01-30 2008-07-29 Vascular Control Systems, Inc. Treatment for post partum hemorrhage
US7651511B2 (en) 2003-02-05 2010-01-26 Vascular Control Systems, Inc. Vascular clamp for caesarian section
US7333844B2 (en) 2003-03-28 2008-02-19 Vascular Control Systems, Inc. Uterine tissue monitoring device and method
US7325546B2 (en) * 2003-11-20 2008-02-05 Vascular Control Systems, Inc. Uterine artery occlusion device with cervical receptacle
US7686817B2 (en) 2003-11-25 2010-03-30 Vascular Control Systems, Inc. Occlusion device for asymmetrical uterine artery anatomy
US20060015144A1 (en) * 2004-07-19 2006-01-19 Vascular Control Systems, Inc. Uterine artery occlusion staple
US7875036B2 (en) 2004-10-27 2011-01-25 Vascular Control Systems, Inc. Short term treatment for uterine disorder
US20100197601A1 (en) * 2007-09-11 2010-08-05 Dorian Bevec Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
RU2010113975A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) (D-Leu)-ГИСТРЕЛИН В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО СРЕДСТВА
CN101555274B (zh) * 2009-05-15 2013-08-21 海南双成药业股份有限公司 一种多肽固相合成比法卢定粗品的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116818A (en) * 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
EP0477499B1 (de) * 1990-08-04 1994-01-26 Hoechst Aktiengesellschaft Gonadoliberin-Antagonisten
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists

Also Published As

Publication number Publication date
PT796622E (pt) 2003-12-31
DE69724682T2 (de) 2004-07-15
EP0796622A3 (de) 1999-02-24
US5691314A (en) 1997-11-25
USRE40119E1 (en) 2008-02-26
EP0796622B1 (de) 2003-09-10
EP0796622A2 (de) 1997-09-24
DK0796622T3 (da) 2004-01-12
ES2206622T3 (es) 2004-05-16
DE69724682D1 (de) 2003-10-16

Similar Documents

Publication Publication Date Title
ATE249233T1 (de) Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen
Ichikawa et al. Bleomycin treatment of the tumors of penis and scrotum
ATE222489T1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
IL127384A0 (en) Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
DE69022722T2 (de) Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
DE3485581D1 (de) Antioestrogenes arzneimittel zur perkutanen verabreichung.
DE69433889D1 (de) Anwendung von 1,2,4-benzotriazinoxiden zur Herstellung eines Arzneimittels zur Behandlung von Tumoren
ATE106730T1 (de) Antigestagen- und antiöstrogenwirksame verbindungen zur behandlung hormonabhängiger tumoren.
JP2003524577A5 (de)
ATE76296T1 (de) Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie.
SE8802569D0 (sv) Improvements in or relation to somatostatins
SE9700642D0 (sv) Medel och sätt för förebyggande och behandling av det metabola syndromet
DE69332353T2 (de) Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs
DE69914084D1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
ES2017808A6 (es) Un metodo para prepara una composicion para inhibir el crecimiento indeseado o patologico de celulas o tejidos.
ATE131060T1 (de) Chenodeoxycholsäure oder ursodeoxycholsäure zur behandlung von erkrankungen der atmungsorgane.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
ATE428438T1 (de) Tcf-ii enthaltende medizinische zusammensetzung
DE59904042D1 (de) Medikament zur prophylaxe und/oder behandlung des mammarkarzinoms enthaltend einen steroidalen aromataseinhibitor
Fine et al. Hypersensitivity dermatitis following suction-assisted lipectomy: a complication of local anesthetic
DE3575732D1 (de) Verwendung von gonadoliberin und gonadoliberinagonisten zur herstellung einer pharmazeutischen zubereitung.
ATE42201T1 (de) Verwendung von phytosterolglycosiden zur herstellung von arzneimitteln zur behandlung von erhoehtem 5(6)alpha-epoxycholesterolgehalt.
Burger et al. Calcification XIX. Calcification of Transplanted Rachitic Bone.
Brown The pressor effects of angiotensin II

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0796622

Country of ref document: EP

RZN Patent revoked